Skip to main content

VYLR · Vylor Inc.

Track VYLR — free
$67.77 -2.05 (-2.94%) At close · Nov 19
Market Cap
$45.22B
Shares
667.30M
Volume · Nov 19 4.04M Avg daily vol (36 sessions) 5.1M

Price & Indicators

 

Key stats

Close
$67.77
Open
$70.04
Day range
$67.70–70.55
Available closing range
$67.26–76.94
Average volume, 30 days
3.8M
Short interest
13.9M · 2.1% of shares · 4.1 days
Short volume, last session
34%
Last earnings
Nov 12, 2026
Latest filing
10-Q · Nov 12
Price history
Oct 2026 to Nov 2026

The closing range uses available history since Oct 1, 2026; less than a full year is stored.

Latest documents

2026
Nov 12
Earnings call
Reaffirms 2026 guidance as licensing drives growth

VILOR reaffirmed 2026 guidance for approximately $10.4 billion in net sales and $2.8 billion operating EBITDA, expecting about 27% margin; licensing gains supported growth, while Q3 sales declined 1% amid weather and Brazil’s licensing transition.

4 source passages
We are reaffirming our full year, 2026 guide that we provided at our investor day. We continue to expect approximately $10.4 billion of net sales, or roughly 3% growth versus prior year, supported by broad-based organic growth and the incremental benefit of controllable levers. Operating EBITDA is expected to be approximately $2.8 billion, representing about 10% growth. With operating EBITDA margin of approximately 27%. Third quarter net sales were down 1%, with price and mix up 6%, and volumes He's down 9%. These volume declines reflect three primary factors. First, favorable early spring weather in North America shifted soybean feed sales into the second quarter, creating a difficult third quarter comparison. Second, historic drought in the MIA and delayed rainfall in Asia-Pacific affected planet area. Third, as we mentioned previously, we deliberately moved away from lower-margin branded seed sales towards a more profitable and capital-efficient licensing model in Brazil soybeans. Our three-year framework, this is a point in time when we're growing corn, we will have some additional licensing costs. Open the document at this passage
Nov 12
Registration statement S-3ASR
Shelf registration enables future sales of multiple securities

Vylor Inc. registered a shelf for future sales of common stock, preferred stock, depositary shares, debt securities, warrants, subscription rights, purchase contracts and purchase units. Proceeds are expected to fund general corporate purposes unless otherwise stated.

Read from the first part of this long document
2 source passages
We may offer, issue and sell, together or separately: Except as otherwise set forth in any accompanying prospectus supplement, we expect to use the net proceeds from the sale of securities for general corporate purposes. Open the document at this passage
Nov 12
Quarterly report 10-Q FY2026 Q3, ended Sep 30
Seed business separation completed

Vylor Inc. became an independent publicly traded company on October 1, 2026 after Corteva’s seed operating segment was separated, creating two independent publicly traded companies.

Revenue $905M ▼ 1.3% Net loss $475M Diluted EPS -$0.85
Read from the MD&A section
Source passage
On October 1, 2026, the company completed its previously announced separation into two independent, publicly traded companies through the separation of Corteva’s seed operating segment into an independent, publicly traded company, Vylor Inc. Open the document at this passage
Nov 12
Current report 8-K Events of Nov 11
Reaffirms 2026 guidance despite third-quarter loss

Vylor Inc. reaffirmed full-year 2026 guidance, expecting Adjusted Pro Forma Operating EBITDA of approximately $2.8 billion and Adjusted Pro Forma Operating EPS of $2.25 to $2.35 per share. Third-quarter GAAP pro forma loss from continuing operations after income taxes was $480 million.

Financial results Read from the first part of this long document
3 source passages
On November 11, 2026, Vylor Inc. (the “Company”) announced its consolidated financial results for the quarter ended September 30, 2026. The Company reiterated full-year 2026 guidance3 and expects Adjusted Pro Forma Operating EBITDA2 to be approximately $2.8 billion. Adjusted Pro Forma Operating EPS2 is expected to be $2.25 to $2.35 per share. GAAP pro forma loss from continuing operations after income taxes1 was $480 million in third quarter of 2026 compared to a loss of $391 million in third quarter of 2025. Open the document at this passage
Nov 12
Current report 8-K
Seed business separation yields 8,531 million pro forma sales

Vylor Inc. completed its separation from Corteva, Inc. on October 1, 2026. Nine-month pro forma sales were 8,531 million, net income attributable to Vylor was 1,005 million, and total assets were 23,194 million as of September 30, 2026.

4 source passages
On October 1, 2026, Corteva, Inc. ("Corteva") completed its previously announced separation into two independent, publicly traded companies - one comprising its Crop Protection Business ("New Corteva" or the "Crop Protection Business") and the other comprising its Seed Business ("Vylor", "the Company", “our,” “we,” or "the Seed Business") - by means of a pro rata distribution of all of the then-outstanding shares of Vylor (inclusive of the Seed Business) common stock to Corteva stockholders in a transaction that is intended to be tax-free to Corteva's stockholders for U.S. federal income tax purposes (the "Vylor Separation"). Summary of Pro Forma Consolidated Statements of Operations (Unaudited) | | | Three Months Ended | | Nine Months Ended | | (In millions, except per share amounts) | | Sep 30, 2026 | Sep 30, 2025 | Sep 30, 2026 | Sep 30, 2025 | Net sales | 938 | 944 | 8,531 | 8,235 Net income (loss) from continuing operations attributable to Vylor | (480) | (391) | 1,005 | 1,228 Vylor Inc. | | | | | Unaudited Pro Forma Consolidated Balance Sheet | | As of September 30, 2026 | | (In millions, except share and per share amounts) | Historical Corteva | | Separation of Crop Protection Business | | Other transaction accounting adjustments | | | Pro Forma as of September 30, 2026 | | Total Assets | 43,031 | (19,215) | (622) | 23,194 Open the document at this passage
All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
-1.3%
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$1.12B
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
-1.6%
Year over year · fewer shares
Price change (1Y)
—
Trailing year
Short interest
2.1%
Latest settlement · 4.1 days to cover
View all 125 metrics

Equibles Rating

blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical Sell Momentum Limited Sentiment Bullish Fundamentals Excellent Quant / Vol Moderate
Market backdrop VIX 28.4 · fear Equity put/call 0.72
Technical
price trend
Sell
50 / 200-day cross No cross
RSI (14) 40
neutral
MACD trend Negative
52-week position 5%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Limited
Not enough data for a confident read.
Sentiment
smart money
Bullish
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Accumulating
+5 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
2.09% of shares out · ▼ -7.0% MoM · 4.1 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
5 holders — 13F breadth
Squeeze score 61
elevated · 0–100
Fundamentals
Excellent
Buyback $3.0B
authorized
Balance sheet $835.0M
net cash
Quant / Vol
risk profile
Moderate
Volatility 42%
annualized · 1-yr
Max drawdown −12%
past year
ATR 4.4%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the Earnings Call filed Nov 12, 2026
full year 2026
Net sales Non-GAAP $10.4B
Net sales growth Non-GAAP 3%
Operating EBITDA margin Non-GAAP 27%
Operating EBITDA Non-GAAP $2.8B
Operating EBITDA growth Non-GAAP 10%
Base tax rate 24% – 26%
future growth
Reinvesting roughly 10% of sales into our future growth 10%
2027 through 2029
Annual operating EBITDA growth Non-GAAP 7% – 8%
Annual net sales growth Non-GAAP 3% – 4%
Annual share repurchases $1B
Average free cash flow conversion 60%
By 2029
Operating EBITDA margin Non-GAAP 30%
average
Average free cash flow conversion 60%
annual
Annual share repurchases $1B
full year, 2026
Net sales growth 3%
Operating EPS $2.25 – $2.35
Operating EPS growth 5%
From 2027 through 2029
Annual net sales growth 3% – 4%
Annual operating EBITDA growth 7% – 8%
2027
Licensing revenue $100M
end the year
Financial debt in total $2.5B
the fourth quarter
Cash $3.5B – $4B

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Sell
2 · 3 · 0
50 / 200-day cross
No cross Neutral
RSI (14)
40 Neutral
MACD trend
Negative Bearish
52-week position
5% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Accumulating
+5 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
2.09% of shares out · ▼ -7.0% MoM · 4.1 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
5 holders — 13F breadth
Price context
position in its available closing range
Range low $67 Now $68 · 5% Range high $77

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Adjusted Pro Forma Operating EBITDA non-GAAP $2.66B Nine Months Ended September 30, 2026 —
Adjusted Pro Forma Operating EPS (Non-GAAP) non-GAAP $2.37 Nine Months Ended September 30, 2026 —
Adjusted pro forma segment operating EBITDA non-GAAP $92M third quarter of 2026 —
Approximate Value of Shares that May Yet Be Purchased Under the Program $1.93B the three months ended September 30, 2026 filing —
Base income tax rate from continuing operations (Non-GAAP) non-GAAP 24.4% Nine Months Ended September 30, 2026 —
Base income tax rate from continuing operations, post-management adjustment (Non-GAAP) non-GAAP 24.4% Nine Months Ended September 30, 2026 —
Exchange gains (losses), net effect non-GAAP -0.3% Nine Months Ended September 30, 2026 —
Operating Earnings (Loss) (Non-GAAP) non-GAAP -$276M the three months ended September 30, 2026 filing —
GAAP → non-GAAP reconciliation
GAAP Income (loss) from continuing operations attributable to Corteva common stockholders (GAAP) -529M
+0M Non-operating benefits (costs), after tax
+105M Amortization of intangibles (existing as of Corteva Separation), after tax
-4M Mark-to-market gains (losses) on certain foreign currency contracts not designated as hedges, after tax
+66M Significant items benefit (charge), after tax
+86M Separation costs, after tax
= Operating Earnings (Loss) (Non-GAAP) -276M
Operating Earnings (Loss) Per Share (Non-GAAP) non-GAAP -$0.41 the three months ended September 30, 2026 filing —
GAAP → non-GAAP reconciliation
GAAP Earnings (loss) per share of common stock from continuing operations attributable to Corteva com -$0.79
+$0 Non-operating benefits (costs), after tax
+$0.16 Amortization of intangibles (existing as of Corteva Separation), after tax
-$0.01 Mark-to-market gains (losses) on certain foreign currency contracts not designated as hedges, after tax
+$0.1 Significant items benefit (charge), after tax
+$0.13 Separation costs, after tax
= Operating Earnings (Loss) Per Share (Non-GAAP) -$0.41
Operating EBITDA non-GAAP -$68M the three months ended September 30, 2026 filing —
Pro Forma Operating EBITDA non-GAAP $2.61B Nine Months Ended September 30, 2026 —
Pro Forma Organic Change non-GAAP -30% Q3 2026 vs. Q3 2025 —
Pro Forma Organic Sales non-GAAP $8.41B Nine Months Ended September 30, 2026 —
Rest of World Adj. Pro Forma Segment Op. EBITDA non-GAAP $92M third quarter of 2026 —
Segment operating EBITDA (Crop Protection) 213M the three months ended September 30, 2026 filing —
Segment operating EBITDA (Seed) -246M the three months ended September 30, 2026 filing —
Segment operating EBITDA (Total) -33M the three months ended September 30, 2026 filing —
Trade receivables sold under these agreements $14M the three months ended September 30, 2026 filing —
YTD Rest of World Adj. Pro Forma Segment Op. EBITDA non-GAAP $555M first nine months of 2026 —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Shell Companies — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
VYLR
Vylor Inc.
this stock
$45.22B — — — 2.1%
CLUS
Cluster Group Holdings Ltd Co
$8.00B — — — —
DMII
Drugs Made In America Acquisition II Corp.
$652.92M +3.5% — — 0.2%
BCSS
Bain Capital GSS Investment Corp.
$607.94M +3.3% — — 0.0%
EVAC
EQV Ventures Acquisition Corp. II
$606.69M +3.5% — — 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
5
% held
0.0%
Net QoQ
+14.2K sh
Top holder
STALEY CAPITAL ADVISERS I…
Held Float
View
Short & Settlement
Short Interest Falling
Shares short
13.9M
Days to cover
4.1d
Change
-1.0M sh
View
Short Volume
Short vol %
34%
As of
Nov 19, 2026
Short Total
View
Fails to Deliver
FTD shares
58
Value
$4.1K
As of
Oct 23, 2026
View
Off-Exchange
Off-exchange %
48.9%
Week of
Oct 12, 2026
Off-exch Lit
View
Financials
Buybacks
Authorized
$3.0B
View
Filings
SEC Filings
Latest
S-3ASR
Filed
Nov 12, 2026
This year
15

Vylor Inc. registered a shelf for future sales of common stock, preferred stock, depositary shares, debt securities, warrants, subscription rights, purchase contracts and purchase units. Proceeds are expected to fund general corporate purposes unless otherwise stated.

View
Earnings & Events
Webcasts
Last webcast
Nov 12, 2026
View
Investor Relations
Latest news
Vylor Reaffirms Full-Year Guidanc…
Published
Nov 11, 2026
View

Performance

5D 20D 120D MTD YTD
VYLR -6.0% -4.7% — -6.4% —
SPY -5.5% -6.3% -5.6% -5.3% +5.0%
vs SPY -0.5% +1.6% — -1.1% —

Capital returns

Declared · upcoming
$0.13 / share · ex Nov 30, 2026
Paid (TTM)
$0.00 / share · 0 payouts
Dividend yield (TTM, derived)
— · no payout in the trailing year
Buyback program · as of Nov 12, 2026
Authorized
$3.00B
Spent (derived)
—
Remaining
—

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 2128626 CUSIP 92892R108 13F (30d) 4 filings 4 filers Visit website Investor relations